HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NSrp70 suppresses metastasis in triple-negative breast cancer by modulating Numb/TβR1/EMT axis.

Abstract
Alternative splicing of mRNA precursors allows cancer cells to create different protein isoforms that promote growth and survival. Compared to normal cells, cancer cells frequently exhibit a higher diversity of their transcriptomes. A comprehensive understanding of splicing regulation is required to correct the splicing alterations for the future precision oncology. A quantitative proteomic screen was performed to identify the regulators associated the metastasis in triple-negative breast cancer. Multiple in vitro and in vivo functional analyses were used to study the effects of NSrp70 on breast cancer metastasis. Next, transcriptomic sequencing (RNA-seq) and alternative splicing bioinformatics analysis was applied to screen the potential targets of NSrp70. Moreover, in vitro splicing assays, RNA pull-down, and RNA immunoprecipitation assay were used to confirm the specific binding between NSrp70 and downstream target genes. Furthermore, the prognostic value of NSrp70 was analyzed in a cohort of patients by performing IHC. We uncovered NSrp70 as a novel suppressor of breast cancer metastasis. We discovered that NSrp70 inhibited the skipped exon alternative splicing of NUMB, promoted the degradation of transforming growth factor receptor 1 through lysosome pathway, and regulated TGFβ/SMAD-mediated epithelial-mesenchymal transition phenotype in breast cancer cells. Furthermore, high NSrp70 expression correlated with a better prognosis in breast cancer patients. Our findings revealed that splicing regulator NSrp70 serves as a metastasis suppressor.
AuthorsYang Zhao, Hefen Sun, Yuanyuan Zhao, Qiqi Liu, Yang Liu, Yifeng Hou, Wei Jin
JournalOncogene (Oncogene) Vol. 41 Issue 25 Pg. 3409-3422 (06 2022) ISSN: 1476-5594 [Electronic] England
PMID35568738 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Chemical References
  • Membrane Proteins
  • NSRP1 protein, human
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • NUMB protein, human
  • RNA Precursors
  • Receptor, Transforming Growth Factor-beta Type I
Topics
  • Alternative Splicing
  • Breast Neoplasms (pathology)
  • Cell Line, Tumor
  • Epithelial-Mesenchymal Transition (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Membrane Proteins (genetics, metabolism)
  • Neoplasm Metastasis
  • Nerve Tissue Proteins (genetics)
  • Nuclear Proteins (metabolism)
  • Precision Medicine
  • Proteomics
  • RNA Precursors
  • Receptor, Transforming Growth Factor-beta Type I (metabolism)
  • Triple Negative Breast Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: